Medication info
Gledin Tablets (Glimepiride)

Gledin Tablets (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Samjin Pharmaceutical Co., Ltd.
Appearance
Green rectangular tablets
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 200401743 · Notified 2004.02.09 · Insurance code 647800110

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit with doses above 4 mg, but some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering medicine to this medicine There is no exact dose equivalence between this medicine and other oral blood glucose-lowering medicines. When switching to this medicine from another oral blood glucose-lowering medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly corrected by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully treated initially during administration of a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is used in combination with metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Samjin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used as an adjunct to diet and exercise to improve blood glucose control in patients with type 2 diabetes. It can also be administered as monotherapy, and in cases where control is difficult with oral hypoglycemics alone, it may be combined with insulin. Additionally, if control is difficult with sulfonylureas or metformin as monotherapy, it can be combined with metformin for more effective blood glucose control. Thus, this medication is utilized to improve blood glucose control according to various therapeutic situations.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit with doses above 4 mg, but some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering medicine to this medicine There is no exact dose equivalence between this medicine and other oral blood glucose-lowering medicines. When switching to this medicine from another oral blood glucose-lowering medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly corrected by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully treated initially during administration of a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is used in combination with metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a comatose state. It is also advisable to avoid its use in patients who have had an allergic reaction to this medication or its components, or in those with severe liver or kidney dysfunction. Pregnant women or women who might become pregnant, and breastfeeding women should also avoid using this medication. In cases of severe infections, surgeries, or severe trauma, insulin therapy is recommended, so this medication should be avoided. Patients with gastrointestinal disorders should be cautious as difficulty absorbing food may increase the risk of hypoglycemia. This medication contains lactose and should not be administered to patients with lactose intolerance or certain genetic conditions. The initial risk of hypoglycemia is high, so special observation is necessary, particularly in elderly patients or those with poor nutritional status, those skipping meals, and patients with weakened kidney or liver function. Caution should also be exercised when consuming alcohol or combining with other medications, as this may increase the risk of hypoglycemia. Patients with an allergy to Yellow No. 4 should also be administered this medication with caution. Symptoms of hypoglycemia may manifest as headaches, severe hunger, nausea, tiredness, confusion, drowsiness, and decreased consciousness. In cases of hypoglycemia, it is essential to ingest sugar to rapidly alleviate symptoms, and in severe cases, urgent treatment from medical personnel is required. Temporary visual disturbances or gastrointestinal symptoms (nausea, vomiting, abdominal pain, etc.) may occur, and abnormal liver function or blood symptoms may rarely occur. Allergic reactions including skin rashes, itching, and severe cases like respiratory distress or shock may present, and if such symptoms arise, medical personnel should be notified immediately. This medication should be taken regularly alongside dietary management and exercise, and it is crucial to regularly check blood glucose control status. To prevent hypoglycemia, patients should comprehensively understand sugar intake methods and symptoms of hypoglycemia, and it is advisable to always carry sugar for emergencies. This medication may interact with other medications, so if there are other medications being taken, informing a doctor or pharmacist is essential. Especially when combined with medications metabolized by the liver, caution is needed as it may affect blood glucose control. Pregnant or breastfeeding women should refrain from using this medication and switch to insulin treatment for safety. Safety in children under 18 years has not been confirmed, so it is preferable not to use this medication in that age group. In elderly patients, dose adjustments may be necessary due to possible increased drug concentrations from decreased kidney function. In case of an overdose, severe hypoglycemia may occur, and immediate medical attention is required. In emergencies, intravenous glucose administration should be conducted promptly to normalize blood glucose levels. This medication should be stored out of the reach of children and kept in its original container to maintain the safety and efficacy of the drug.

Side effects

  • Hypoglycemia
  • headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep
  • sleep disorders
  • anxiety
  • aggression
Show 68 more
  • decreased concentration
  • decreased agility or motivation
  • depression
  • confusion
  • speech abnormalities
  • aphasia
  • visual impairment
  • tremors
  • partial paralysis
  • sensory abnormalities
  • dizziness
  • lethargy
  • loss of self-control
  • temporary mental confusion
  • seizures
  • drowsiness
  • loss of consciousness
  • coma
  • shallow breathing
  • bradycardia
  • sweating
  • cold and clammy skin
  • tachycardia
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis
  • blurred vision
  • fullness in the upper abdomen
  • pressure sensation
  • abdominal pain
  • diarrhea
  • increased liver enzymes
  • liver dysfunction
  • bile secretion disorders
  • jaundice
  • hepatitis
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythrocytopenia
  • neutropenia
  • agranulocytosis
  • pancytopenia
  • itching
  • urticaria
  • rash
  • dyspnea
  • hypotension
  • shock
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • allergic vasculitis
  • phototoxic reactions of the skin
  • decreased serum sodium concentration
  • dysgeusia
  • hair loss
  • weight gain
  • dizziness
  • liver dysfunction
  • abdominal pain
  • arthralgia
  • indigestion
  • facial edema
  • erectile dysfunction
  • facial flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to keep it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the drug's efficacy for a longer period.

Appearance and packaging

Appearance

Green rectangular tablets

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.